CT SB01202 | 2023 | General Assembly
Status
Spectrum: Committee Bill
Status: Introduced on March 9 2023 - 25% progression, died in committee
Action: 2023-03-21 - Joint Favorable Change of Reference Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 9 2023 - 25% progression, died in committee
Action: 2023-03-21 - Joint Favorable Change of Reference Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To (1) require that certain prescription drugs purchased in the state not exceed upper payment limits set by Medicare pursuant to the federal Inflation Reduction Act, (2) establish a Prescription Drug Payment Evaluation Committee to recommend upper payment limits on not less than eight drugs based on such limits in other states or countries, and (3) require the Office of Health Strategy to monitor and make public the costliest prescription drugs.
Title
An Act Concerning Prescription Drug Affordability.
Sponsors
Roll Calls
2023-03-21 - Joint - HS Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-21 - Joint - HS Vote Tally Sheet (MOTION FAILED) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-21 - Joint - HS Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-21 - Joint - HS Vote Tally Sheet (MOTION FAILED) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-21 - Joint - HS Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-03-21 | Senate | Joint Favorable Change of Reference Insurance and Real Estate |
2023-03-10 | Senate | Public Hearing 03/16 |
2023-03-09 | Senate | Referred to Joint Committee on Human Services |